Werkgroep Cardiologische centra Nederland

DELIVER (Follow-up)

An International, Double-blind, Randomised Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Morbidity and Mortality in Patients with HFpEF
Medicine
dapagliflozin
Population
Heart failure
Phase
III
Starting year
2017
More information
Clinicaltrials.gov